MILTON C. AULT, III 13D and 13G filings for Alzamend Neuro, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-08-01 8:52 pm Purchase |
2025-07-23 | 13D | Alzamend Neuro, Inc. ALZN |
MILTON C. AULT, III | 706,322 18.500% |
706,322![]() (New Position) |
Filing |